<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ross JP</submitter><funding>National Heart Foundation of Australia</funding><funding>Science and Industry Endowment Fund</funding><funding>Diabetes Australia</funding><pagination>58</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9055778</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Genomic technologies can be subject to significant batch-effects which are known to reduce experimental power and to potentially create false positive results. The Illumina Infinium Methylation BeadChip is a popular technology choice for epigenome-wide association studies (EWAS), but presently, little is known about the nature of batch-effects on these designs. Given the subtlety of biological phenotypes in many EWAS, control for batch-effects should be a consideration.&lt;h4>Results&lt;/h4>Using the batch-effect removal approaches in the ComBat and Harman software, we examined two in-house datasets and compared results with three large publicly available datasets, (1214 HumanMethylation450 and 1094 MethylationEPIC BeadChips in total), and find that despite various forms of pr</pubmed_abstract><journal>Clinical epigenetics</journal><pubmed_title>Batch-effect detection, correction and characterisation in Illumina HumanMethylation450 and MethylationEPIC BeadChip array data.</pubmed_title><pmcid>PMC9055778</pmcid><funding_grant_id>Future Leader Fellowship</funding_grant_id><funding_grant_id>RP03-064</funding_grant_id><pubmed_authors>van Dijk S</pubmed_authors><pubmed_authors>Molloy PL</pubmed_authors><pubmed_authors>Oytam Y</pubmed_authors><pubmed_authors>Skilton MR</pubmed_authors><pubmed_authors>Ross JP</pubmed_authors><pubmed_authors>Phang M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Batch-effect detection, correction and characterisation in Illumina HumanMethylation450 and MethylationEPIC BeadChip array data.</name><description>&lt;h4>Background&lt;/h4>Genomic technologies can be subject to significant batch-effects which are known to reduce experimental power and to potentially create false positive results. The Illumina Infinium Methylation BeadChip is a popular technology choice for epigenome-wide association studies (EWAS), but presently, little is known about the nature of batch-effects on these designs. Given the subtlety of biological phenotypes in many EWAS, control for batch-effects should be a consideration.&lt;h4>Results&lt;/h4>Using the batch-effect removal approaches in the ComBat and Harman software, we examined two in-house datasets and compared results with three large publicly available datasets, (1214 HumanMethylation450 and 1094 MethylationEPIC BeadChips in total), and find that despite various forms of pr</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Apr</publication><modification>2026-05-31T01:08:36.397Z</modification><creation>2025-04-03T22:51:13.196Z</creation></dates><accession>S-EPMC9055778</accession><cross_references><pubmed>35488315</pubmed><doi>10.1186/s13148-022-01277-9</doi></cross_references></HashMap>